CTMX cytomx.com: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan

The stock price retrospective for CytomX Therapeutics (CTMX) demonstrates an EV/EBITDA of 0.00. CytomX Therapeutics develops solutions for the targeted destruction of tumors through collaborations with industry behemoths. The current drug portfolio minimizes side effects via the local activation of therapy. Meanwhile, the business relies on external contractors for manufacturing and testing, maintaining its status as a mobile research center.

CTMX CytomX Therapeutics Inc: Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan ing interval 23.11.2025 - 11.11.2026

Rincian metrik lan analitis perusahaan cytomx.com (CTMX)

- rega saham lan target rega konsensus:

Kutipan saham CytomX Therapeutics Inc|CTMX - Rata-rata rega prakiraan

- data kapitalisasi saham perusahaan:

Biji pasar CytomX Corp|CTMX - Nilai Dipunlarasaken Utang lan Kas

- rincian valuasi buku bisnis:

Aset Bersih saben Siji Saham CytomX Therapeutics|CTMX - Nilai Aset Bersih|Rasio Nilai Pasar marang Nilai Buku cytomx.com|CTMX - Aset Agregat Perusahaan

- informasi babagan utang lan solvabilitas:

Total Utang marang Modal CytomX Therapeutics|CTMX - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas CytomX Therapeutics, Inc.|CTMX - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku CytomX Corp|CTMX - Kewajiban jangka dawa|Utang jangka cendhak perusahaan CytomX Therapeutics|Likuiditas cepet cytomx.com

- data bathi bisnis lan rasio investasi:

CTMX - Bathi pungkasan|Bathi sing dikarepake CytomX Therapeutics|CTMX - Koefisien rega marang bathi|Rega marang bathi mangsa ngarep CytomX Therapeutics|CTMX - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA CytomX Corp|CTMX - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan CytomX Therapeutics|CTMX - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan cytomx.com|CTMX - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep CytomX Therapeutics

Analisis umum perusahaan:CytomX Therapeutics Inc CTMX

CytomX Therapeutics (CTMX) develops oncology programs through external funding from strategic partners. The enterprise value to EBITDA multiple compares the total asset price to its cash flow, excluding the impact of taxes and debt load. This chart's price action allows for the filtering of market noise to assess the real value of the business. The stability of this indicator confirms the company's fundamental resilience.

Pesaing langsung